Genotoxicity
In genotoxicity DNA is damage. Substances that are genotoxic may bind directly to DNA or act indirectly showing to DNA damage by attacking enzymes involved in DNA replication, thereby causing mutations which may or may not show to cancer or birth defects (inheritable damage).
Related Conference of Genotoxicity
November 27-28, 2025
7th International Conference on Clinical Pharmacology and Toxicology
Zurich, Switzerland
Genotoxicity Conference Speakers
Recommended Sessions
- Behavior toxicology
- Bio-availability
- Bio-equivalence
- Biochemical Pharmacology
- Biologic drugs
- Clinical and medical pharmacology
- Drug discovery and Drug development
- Drug Safety
- Environmental Toxicology
- Genotoxicity
- Microbial Toxicology
- Molecular Pharmacology
- Nanomedicine and Nanotechnology
- Pharmaceutical biotechnology
- Pharmacodynamics
- Pharmacogenomics
- Pharmacokinetics
- Pharmacology and Toxicology
- Pharmacovigilance
- Route of administration
Related Journals
Are you interested in
- Adverse Drug Reactions and Pharmacovigilance - clinical pharmacology 2025 (Switzerland)
- Cardiovascular Pharmacology - clinical pharmacology 2025 (Switzerland)
- Clinical Toxicology of Drugs of Abuse - clinical pharmacology 2025 (Switzerland)
- Clinical Trials and Regulatory Affairs - clinical pharmacology 2025 (Switzerland)
- Drug Interactions and Polypharmacy - clinical pharmacology 2025 (Switzerland)
- Emerging Trends in Clinical Pharmacology - clinical pharmacology 2025 (Switzerland)
- Environmental and Occupational Toxicology - clinical pharmacology 2025 (Switzerland)
- Future Directions in Clinical Pharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Innovations in Drug Development and Therapeutics - clinical pharmacology 2025 (Switzerland)
- Natural Products and Toxicology - clinical pharmacology 2025 (Switzerland)
- Neuropharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Pediatric and Geriatric Pharmacology - clinical pharmacology 2025 (Switzerland)
- Pharmacogenomics and Personalized Medicine - clinical pharmacology 2025 (Switzerland)
- Pharmacokinetics and Pharmacodynamics - clinical pharmacology 2025 (Switzerland)
- Toxicology and Risk Assessment - clinical pharmacology 2025 (Switzerland)